Skip to main content

Table 2 Operative and pathological details and outcomes

From: Tumor infiltrating B-cells are increased in prostate cancer tissue

  ALL (n = 53)
Median operative time (IQR), mins 189 (170–200)
Median estimated blood loss (IQR), mL 150 (100–200)
Median prostate weight (IQR), gm 44.7 (38–57.1)
Blood transfusions 1 (1.8%)
Lymph node dissection 37 (69.8%)
Complete nerve sparing 37 (69.8%)
Median hospital stay (IQR), days 1 (1–1)
Median lymph nodes retrieved (IQR) 17 (12–21)
Positive LN 5 (9.4%)
Median tumor size (IQR), cc 6.9 (2.6–13.7)
Positive margins 20 (41.5%)
Seminal vesicle involvement 6 (11.3%)
Extra capsular extension 15 (28.3%)
Perineural invasion 44 (83.0%)
Extensive prostatic intraepithelial neoplasia 5 (9.4%)
Vascular/Lymphatic invasion 10 (18.8%)
Pathologic T stage  
 T2a-c 29 (54.7%)
 T3a-b 21 (39.6%)
 T4 3 (5.7%)
Pathologic Gleason score  
 ≤ 6 13 (24.5%)
 7 16 (30.2%)
 ≥ 8 24 (45.3%)